Page 54 - NobleCon21

Materials
Date November 20, 2025 Materials
52wk High $0.32
52wk Low $0.14 BioLargo, Inc. BLGO $0.15
14921 Chestnut Street
Westminster, CA 92683

(USD - in millions) www.biolargo.com
Market Cap 48.1
Enterprise 44.0
Basic Shares Out. 312.55 COMPANY OVERVIEW
Float 269.11
Institutional Holdings 0.04% Detailed Analysis:Channelchek.com
Short Interest 0.14
Avg. 90-Day Volume 0.50 BioLargo, Inc. is a cleantech and life sciences innovator and
engineering services solution provider. Our core products address
PFAS contamination, achieve advanced water and wastewater
treatment, control odor and VOCs, improve air quality, enable energy-
EPS Data efficiency and safe on-site energy storage, and control infections and
infectious disease. Our approach is to invent or acquire novel
2022 2023 2024 technologies, develop them into product offerings, and extend their
CQ1 N/A N/A (0.00) commercial reach through licensing and channel partnerships to
CQ2 N/A N/A (0.00) maximize their impact.

CQ3 N/A (0.01) (0.00)
CQ4 N/A (0.01) (0.01)
CY N/A (0.02) (0.01) Source: Channelchek/QuoteMedia

Long-Term EPS Estimate 15.00
Price/Book (mrq) 0.02
ROE (ttm) -277.93
Debt-to-Total Cap. (mrq) 54.23
Fiscal Year End 31-Dec
14921 Chestn Westminster CA 92683

Key Executives
CEO: Calvert, Dennis
CFO: Dargan, Charles
COO: Provenzano, Joseph
IR: N/A
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Joe Gomes MEMBERS: FINRA, SIPC, MSRB
jgomes@noblecapitalmarkets.com Following the conference, complete video library of presentations will be
available at: channelchek.com | nobleconference.com
(561) 999-2262

Refer to the back of the book for disclosures